Monika Hansson

2.0k total citations
51 papers, 1.3k citations indexed

About

Monika Hansson is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Monika Hansson has authored 51 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Rheumatology, 36 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Immunology. Recurrent topics in Monika Hansson's work include Monoclonal and Polyclonal Antibodies Research (36 papers), Rheumatoid Arthritis Research and Therapies (32 papers) and Systemic Lupus Erythematosus Research (22 papers). Monika Hansson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (36 papers), Rheumatoid Arthritis Research and Therapies (32 papers) and Systemic Lupus Erythematosus Research (22 papers). Monika Hansson collaborates with scholars based in Sweden, France and Germany. Monika Hansson's co-authors include Lars Klareskog, Johan Rönnelid, Rikard Holmdahl, Per‐Johan Jakobsson, Linda Mathsson‐Alm, Lena Israelsson, Karin Lundberg, Guy Serre, Vivianne Malmström and Anca I. Catrina and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and The American Journal of Human Genetics.

In The Last Decade

Monika Hansson

48 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monika Hansson Sweden 21 933 561 368 140 111 51 1.3k
Aase Hensvold Sweden 19 747 0.8× 315 0.6× 344 0.9× 245 1.8× 114 1.0× 49 1.2k
E. W. Nivine Levarht Netherlands 18 1.1k 1.1× 561 1.0× 501 1.4× 207 1.5× 189 1.7× 26 1.6k
Lotte A van de Stadt Netherlands 15 1.3k 1.4× 674 1.2× 467 1.3× 237 1.7× 254 2.3× 30 1.7k
K. N. Verpoort Netherlands 13 1.5k 1.6× 760 1.4× 378 1.0× 114 0.8× 205 1.8× 17 1.8k
Gabriella Morozzi Italy 23 962 1.0× 385 0.7× 492 1.3× 189 1.4× 125 1.1× 57 1.4k
Mary H. Foster United States 16 545 0.6× 426 0.8× 710 1.9× 227 1.6× 30 0.3× 53 1.2k
Dag Leonard Sweden 24 968 1.0× 246 0.4× 933 2.5× 247 1.8× 94 0.8× 51 1.5k
María‐Eugenia Miranda‐Carús Spain 17 465 0.5× 120 0.2× 529 1.4× 188 1.3× 118 1.1× 30 1.0k
Claudia Azucena Palafox‐Sánchez Mexico 20 460 0.5× 121 0.2× 592 1.6× 183 1.3× 69 0.6× 63 1.0k
D. van Schaardenburg Netherlands 9 628 0.7× 209 0.4× 178 0.5× 53 0.4× 149 1.3× 34 747

Countries citing papers authored by Monika Hansson

Since Specialization
Citations

This map shows the geographic impact of Monika Hansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monika Hansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monika Hansson more than expected).

Fields of papers citing papers by Monika Hansson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monika Hansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monika Hansson. The network helps show where Monika Hansson may publish in the future.

Co-authorship network of co-authors of Monika Hansson

This figure shows the co-authorship network connecting the top 25 collaborators of Monika Hansson. A scholar is included among the top collaborators of Monika Hansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monika Hansson. Monika Hansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klint, Erik af, Monika Hansson, Anders Larsson, et al.. (2025). Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13. Clinical Immunology. 275. 110476–110476. 1 indexed citations
2.
Hansson, Monika, Linda Mathsson‐Alm, Vijay Joshua, et al.. (2024). Identification of early risk factors for anti-citrullinated-protein-antibody positive rheumatoid arthritis—a prospective cohort study. Lara D. Veeken. 63(11). 3164–3171. 7 indexed citations
3.
Hansson, Monika, Linda Mathsson‐Alm, Vijay Joshua, et al.. (2023). OP0120 IDENTIFICATION OF EARLY RISK FACTORS IN A NOVEL PREDICTION MODEL FOR ACPA POSITIVE RA. Annals of the Rheumatic Diseases. 82. 78–79. 1 indexed citations
4.
Joshua, Vijay, et al.. (2023). Presence of anti‐modified protein antibodies in idiopathic pulmonary fibrosis. Respirology. 28(10). 925–933. 3 indexed citations
6.
Saevarsdóttir, Saedís, Vivek Anand Manivel, Lars Klareskog, et al.. (2023). In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation. Annals of the Rheumatic Diseases. 83(3). 277–287. 20 indexed citations
7.
Brink, Mikael, Lotta Ljung, Monika Hansson, et al.. (2022). Anti-citrullinated protein antibody specificities and pulmonary fibrosis in relation to genetic loci in early rheumatoid arthritis. Lara D. Veeken. 61(12). 4985–4990. 4 indexed citations
8.
Westerlind, Helga, Alf Kastbom, Johan Rönnelid, et al.. (2022). The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis. Lara D. Veeken. 62(6). 2106–2112. 4 indexed citations
9.
Reed, Evan, Anna Karin Hedström, Monika Hansson, et al.. (2020). Presence of autoantibodies in “seronegative” rheumatoid arthritis associates with classical risk factors and high disease activity. Arthritis Research & Therapy. 22(1). 170–170. 46 indexed citations
10.
Hansson, Monika, et al.. (2019). P023 Tenosynovitis and HLA-SE predict arthritis onset in ACPA-positive individuals at risk of developing rheumatoid arthritis. Annals of the Rheumatic Diseases. 78. A8–A9. 1 indexed citations
11.
Wang, Yan, Katy A. Lloyd, Ioannis N. Melas, et al.. (2019). Rheumatoid arthritis patients display B-cell dysregulation already in the naïve repertoire consistent with defects in B-cell tolerance. Scientific Reports. 9(1). 19995–19995. 50 indexed citations
12.
Oluwagbemigun, Kolade, Tülay Yucel‐Lindberg, Thomas Dietrich, et al.. (2019). A cross-sectional investigation into the association between Porphyromonas gingivalis and autoantibodies to citrullinated proteins in a German population. Therapeutic Advances in Musculoskeletal Disease. 11. 1759720X19883152–1759720X19883152. 7 indexed citations
13.
Sohrabian, Azita, Linda Mathsson‐Alm, Monika Hansson, et al.. (2018). Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis. Annals of the Rheumatic Diseases. 77(9). 1345–1353. 19 indexed citations
14.
Sherina, Natalia, Hulda S. Hreggvidsdottir, Camilla Bengtsson, et al.. (2017). Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology. Arthritis Research & Therapy. 19(1). 219–219. 22 indexed citations
15.
Rönnelid, Johan, Monika Hansson, Linda Mathsson‐Alm, et al.. (2017). Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants. Annals of the Rheumatic Diseases. 77(2). 203–211. 41 indexed citations
16.
Brink, Mikael, Monika Hansson, Linda Mathsson‐Alm, et al.. (2016). Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis. Arthritis Research & Therapy. 18(1). 43–43. 53 indexed citations
17.
Joshua, Vijay, Philip J. Titcombe, Lena Israelsson, et al.. (2016). Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells. Arthritis Research & Therapy. 18(1). 284–284. 20 indexed citations
18.
Kokkonen, Heidi, Mikael Brink, Monika Hansson, et al.. (2015). Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis. Arthritis Research & Therapy. 17(1). 39 indexed citations
19.
Hensvold, Aase, Patrik K. E. Magnusson, Vijay Joshua, et al.. (2013). Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins. Annals of the Rheumatic Diseases. 74(2). 375–380. 127 indexed citations
20.
Ärlestig, Lisbeth, Mikael Brink, Monika Hansson, et al.. (2012). Single Nucleotide Polymorphisms within the HLA-DRB1 Gene in Relation to Antibodies Against Citrullinated Peptides in Individuals Prior to the Development of Rheumatoid Arthritis. Arthritis & Rheumatism. 64(10).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026